S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
South Korea takes steps to suspend licenses of striking doctors after they refuse to end walkouts
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
South Korea takes steps to suspend licenses of striking doctors after they refuse to end walkouts
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
South Korea takes steps to suspend licenses of striking doctors after they refuse to end walkouts
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Stock market today: World markets are mixed and Japan's Nikkei tops 40,000, on eve of China congress
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China seeks ways to revive slowing economy and salvage property market as annual congress convenes
Arkhouse and Brigade up Macy's takeover offer to $6.6 billion following rejection of previous deal
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
OPEC+ production cuts deepen with extensions from Saudi Arabia, Russia and other oil giants
South Korea takes steps to suspend licenses of striking doctors after they refuse to end walkouts

Medicenna Therapeutics (MDNA) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
morningstar.com logoMedicenna Therapeutics Corp MDNA
morningstar.com - March 1 at 2:01 AM
finance.yahoo.com logoMedicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate Update
finance.yahoo.com - February 14 at 10:05 AM
tmcnet.com logoMedicenna Announces Appointment of New Auditor
tmcnet.com - January 12 at 6:05 PM
finance.yahoo.com logoMedicenna Announces Trading on the OTCQB Under the Symbol MDNAF
finance.yahoo.com - December 19 at 7:23 AM
finance.yahoo.com logoMDNA.TO: Overall Survival Data from Phase 2b Trial of Bizaxofusp Presented at SNO 2023…
finance.yahoo.com - November 20 at 5:51 PM
finance.yahoo.com logoMedicenna Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Operational Highlights
finance.yahoo.com - November 14 at 10:03 AM
finance.yahoo.com logoMDNA.TO: Additional Confirmed PR in Phase 1/2 ABILITY Trial of MDNA11
finance.yahoo.com - November 13 at 1:37 PM
finance.yahoo.com logoMedicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
finance.yahoo.com - November 6 at 7:57 AM
finance.yahoo.com logoMedicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
finance.yahoo.com - November 3 at 1:37 PM
msn.com logoWhy Is Medicenna Therapeutics (MDNA) Stock Down Today?
msn.com - October 30 at 9:46 AM
finance.yahoo.com logoMedicenna Announces Nasdaq Delisting and Cutback of Management Team
finance.yahoo.com - October 27 at 8:02 AM
finance.yahoo.com logoMedicenna Therapeutics Doses First Patient in Phase 2 Monotherapy Dose Expansion Portion of the ABILITY Study Evaluating MDNA11 in Select Types of Solid Tumors
finance.yahoo.com - October 25 at 9:37 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp up on Thursday (MDNA)
theglobeandmail.com - October 13 at 12:40 PM
markets.businessinsider.com logoMedicenna Therapeutics Names Humphrey Gardner CMO
markets.businessinsider.com - October 10 at 8:13 AM
finance.yahoo.com logoMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as Chief Medical Officer
finance.yahoo.com - October 10 at 8:13 AM
finance.yahoo.com logoMedicenna Announces Results of Annual and Special Meeting of Shareholders
finance.yahoo.com - September 28 at 6:57 PM
nasdaq.com logoMedicenna Therapeutics (TSE:MDNA) Price Target Decreased by 12.14% to 3.94
nasdaq.com - September 13 at 1:31 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp flat on Monday (MDNA)
theglobeandmail.com - August 22 at 11:51 AM
msn.com logoMDNA: Commences Monotherapy Dose Expansion in Phase 1/2 ABILITY Trial…
msn.com - August 15 at 4:46 PM
markets.businessinsider.com logoThe Latest Analyst Ratings for Medicenna Therapeutics
markets.businessinsider.com - August 14 at 3:22 PM
finance.yahoo.com logoMedicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management
finance.yahoo.com - August 14 at 7:20 AM
benzinga.com logoMedicenna Therapeutics's Earnings: A Preview
benzinga.com - August 8 at 2:50 PM
benzinga.com logoMedicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committee
benzinga.com - August 8 at 9:50 AM
finance.yahoo.com logoMedicenna Appoints Dr. Arash Yavari as Chair of Development Advisory Committee
finance.yahoo.com - August 8 at 9:50 AM
finance.yahoo.com logoMedicenna Therapeutics to Provide Clinical Update from Phase 1/2 ABILITY Study on August 9, 2023
finance.yahoo.com - August 4 at 4:50 PM
finance.yahoo.com logoMedicenna Strengthens IP Portfolio with U.S. Patent Granted for the Use of Interleukin-2 Superkine Fusion Proteins in Oncology
finance.yahoo.com - August 1 at 11:29 AM
markets.businessinsider.com logoH.C. Wainwright Thinks Medicenna Therapeutics Corp’s Stock is Going to Recover
markets.businessinsider.com - July 31 at 8:14 AM
finanznachrichten.de logoMedicenna Therapeutics Corp.: Medicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
finanznachrichten.de - July 28 at 10:14 AM
finance.yahoo.com logoMedicenna Reports First Quarter Fiscal 2024 Financial Results and Operational Highlights
finance.yahoo.com - July 28 at 10:14 AM
finance.yahoo.com logoMedicenna Presents at National Brain Tumor Society's Research Round Table
finance.yahoo.com - July 25 at 7:16 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp down on Tuesday (MDNA)
theglobeandmail.com - July 19 at 7:33 AM
finance.yahoo.com logoMDNA: Full MDNA11 Clinical Update in Calendar 3Q23…
finance.yahoo.com - July 6 at 3:06 PM
finanznachrichten.de logoMedicenna Therapeutics Corp.: Medicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights
finanznachrichten.de - June 27 at 12:55 PM
finance.yahoo.com logoMedicenna Reports Fiscal Year 2023 Financial Results and Operational Highlights
finance.yahoo.com - June 27 at 8:59 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp down on Wednesday (MDNA)
theglobeandmail.com - May 18 at 8:34 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp down on Monday (MDNA)
theglobeandmail.com - May 16 at 9:49 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp flat on Friday (MDNA)
theglobeandmail.com - May 6 at 10:21 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp down on Friday (MDNA)
theglobeandmail.com - April 29 at 8:48 AM
finance.yahoo.com logoMedicenna Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
finance.yahoo.com - April 27 at 7:57 AM
theglobeandmail.com logoClosing Bell: Medicenna Therapeutics Corp up on Friday (MDNA)
theglobeandmail.com - April 22 at 8:22 AM
msn.com logoMDNA: Update on ABILITY Trial…
msn.com - April 19 at 4:01 PM
finance.yahoo.com logoHere's Why We're Not Too Worried About Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation
finance.yahoo.com - April 19 at 9:53 AM
finance.yahoo.com logoMedicenna to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 18 at 9:25 AM
finance.yahoo.com logoMedicenna Presents Preclinical IL-13 Superkine Data at the AACR Annual Meeting
finance.yahoo.com - April 17 at 7:21 AM
finance.yahoo.com logoMedicenna Provides Clinical Update from Monotherapy Dose Escalation Portion of Phase 1/2 ABILITY Study
finance.yahoo.com - March 30 at 8:45 AM
finance.yahoo.com logoMedicenna Announces Upcoming Presentation at the AACR Annual Meeting
finance.yahoo.com - March 15 at 8:31 AM
finanznachrichten.de logoMedicenna Therapeutics Corp.: Medicenna Reports Third Quarter Fiscal 2023 Financial Results and Operational Highlights
finanznachrichten.de - February 7 at 2:01 PM
finance.yahoo.com logoMedicenna Reports Third Quarter Fiscal 2023 Financial Results and Operational Highlights
finance.yahoo.com - February 7 at 8:55 AM
finance.yahoo.com logoMedicenna to Present at the 2023 Guggenheim Oncology Conference
finance.yahoo.com - January 31 at 7:59 AM
theglobeandmail.com logoMedicenna Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (MDNA)
theglobeandmail.com - December 10 at 4:39 PM
Get Medicenna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter.



MDNA Media Mentions By Week

MDNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MDNA
News Sentiment

0.00

0.65

Average
Medical
News Sentiment

MDNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MDNA Articles
This Week

1

0

MDNA Articles
Average Week

Get Medicenna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MDNA) was last updated on 3/4/2024 by MarketBeat.com Staff